Table 3. Clinical outcomes of ACS hospitalizations with and without RA.
PTCA: percutaneous transluminal coronary angioplasty; PCI DES: percutaneous coronary intervention with drug-eluting stent; PCI BMS: percutaneous coronary intervention with bare-metal stent; IABP: intra-aortic balloon pump; PEAD: percutaneous external assist devices; thrombolytics: intracoronary artery thrombolytic infusion; CABG: coronary artery bypass graft; OR: odds ratio; CI: confidence interval; USD: United States dollars
* statistically significant
ACS with RA (n=22,615) | ACS without RA (n=1,296,849) | Adjusted OR | p-value | |
% | % | (95% CI) | ||
Primary outcome | ||||
In-hospital mortality | 4.5 | 4.6 | 0.84 (0.72-0.99) | 0.034* |
Secondary outcomes | ||||
PTCA | 4.3 | 5.1 | 0.94 (0.81-1.10) | 0.451 |
PCI DES | 35.4 | 40.5 | 1.14 (1.07-1.23) | <0.0001* |
PCI BMS | 7.1 | 7.9 | 1.01 (0.90-1.14) | 0.884 |
IABP | 2.8 | 4.0 | 0.78 (0.64-0.95) | 0.015* |
PEAD | 0.88 | 1.0 | 1.07 (0.77-1.48) | 0.697 |
Thrombolytics | 0.24 | 0.29 | 1.07 (0.56-2.05) | 0.836 |
CABG | 6.9 | 8.1 | 0.95 (0.83-1.09) | 0.473 |
Adjusted mean difference | ||||
LOS, mean days | 4.6 | 4.4 | -0.18 (- {0.32- 0.05} | 0.009* |
Total charge, mean, USD | 85,273 | 91,889 | -888 ({-3845}-2070) | 0.556 |